{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:22:09Z","timestamp":1792430529882,"version":"4.5.0"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Remarkable discoveries over the last two decades have elucidated the autoimmune basis of several, previously poorly understood, neurological disorders. Autoimmune disorders of the nervous system may affect any part of the nervous system, including the brain and spinal cord (central nervous system, CNS) and also the peripheral nerves, neuromuscular junction and skeletal muscle (peripheral nervous system, PNS). This comprehensive overview of this rapidly evolving field presents the factors which may trigger breakdown of self-tolerance and development of autoimmune disease in some individuals. Then the pathophysiological basis and clinical features of autoimmune diseases of the nervous system are outlined, with an emphasis on the features which are important to recognize for accurate clinical diagnosis. Finally the latest therapies for autoimmune CNS and PNS disorders and their mechanisms of action and the most promising research avenues for targeted immunotherapy are discussed.<\/jats:p>","DOI":"10.3389\/fneur.2021.664664","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T06:25:48Z","timestamp":1618381548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":86,"title":["Autoimmune Disorders of the Nervous System: Pathophysiology, Clinical Features, and Therapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Satyakam","family":"Bhagavati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","article-title":"Updated assessment of the prevalence, spectrum and case definition of autoimmune disease","volume":"11","author":"Hayter","year":"2012","journal-title":"Autoimmun Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/ni.3731","article-title":"The multiple pathways to autoimmunity","volume":"18","author":"Theofilopoulos","year":"2017","journal-title":"Nat Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1073\/pnas.1932604100","article-title":"Canadian collaborative study group. Twin concordance and sibling recurrence rates in multiple sclerosis","volume":"100","author":"Willer","year":"2003","journal-title":"Proc Nat Acad Sci USA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis- a comprehensive review","volume":"52","author":"Avidan","year":"2014","journal-title":"J Autoimmun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2815","article-title":"The X chromosome in immune functions: when a chromosome makes the difference","volume":"10","author":"Libert","year":"2010","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri.2017.143","article-title":"HLA variation and disease","volume":"18","author":"Dendrou","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ni1187","article-title":"Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor","volume":"6","author":"Hahn","year":"2005","journal-title":"Nat Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.24858","article-title":"Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4","volume":"81","author":"van","year":"2017","journal-title":"Ann Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1212\/NXI.0000000000000605","article-title":"HLA and microtubule associated protein tau H1 haplotype associations in anti-IgLON5 disease","volume":"6","author":"Gaig","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA associations of LGI1 and CASPR2-antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain."},{"key":"B14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/ane.12951","article-title":"HLA and MUSK-positive myasthenia gravis: a systematic review and meta-analysis","volume":"138","author":"Hong","year":"2018","journal-title":"Acta Neurol Scand."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e36603","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PLoS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/s41467-018-04332-3","article-title":"A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica","volume":"9","author":"Estrada","year":"2018","journal-title":"Nat Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e83811","DOI":"10.1371\/journal.pone.0083811","article-title":"Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+CD25hi T cells of Type 1 diabetic and multiple sclerosis patients","volume":"8","author":"Cerosaletti","year":"2013","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nature06066","article-title":"An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus","volume":"448","author":"Giraud","year":"2007","journal-title":"Nature."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.cell.2018.09.049","article-title":"International multiple sclerosis genetics consortium. Low-frequency and rare-coding variation contributes to multiple sclerosis risk","volume":"175","author":"Costapas","year":"2018","journal-title":"Cell."},{"key":"B20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/WCO.0000000000000445","article-title":"Postviral autoimmune encephalitis: manifestations in children and adults","volume":"67","author":"Pruss","year":"2006","journal-title":"Neurology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.molmed.2016.10.007","article-title":"Multiple sclerosis-a response-to-damage model","volume":"22","author":"\u2018t","year":"2016","journal-title":"Trends Mol Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1096\/fasebj.12.13.1255","article-title":"Molecular mimicry and immune-mediated diseases","volume":"12","author":"Oldstone","year":"1998","journal-title":"Faseb J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.molimm.2003.11.022","article-title":"Specificity and degeneracy of T cells","volume":"40","author":"Wilson","year":"2004","journal-title":"Mol Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1074\/jbc.M111.289488","article-title":"A single autoimmune T cell receptor recognizes more than a million different peptides","volume":"287","author":"Wooldridge","year":"2012","journal-title":"J Biol Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1084\/jem.20120905","article-title":"Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection","volume":"209","author":"Enouz","year":"2012","journal-title":"J Exp Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain-Barre syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41582-020-0381-z","article-title":"The B cell immunobiology that underlies CNS autoantibody-mediated diseases","volume":"16","author":"Sun","year":"2020","journal-title":"Nat Rev Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.4049\/jimmunol.169.10.5415","article-title":"Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs","volume":"169","author":"de","year":"2002","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis interface","volume":"122","author":"Di","year":"2012","journal-title":"J Clin Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9277","DOI":"10.1073\/pnas.0803644105","article-title":"Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors","volume":"105","author":"Mietzner","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e8879","DOI":"10.15252\/emmm.201808879","article-title":"Dissecting human antibody responses: useful, basic and surprising findings","volume":"10","author":"Lanzavecchia","year":"2018","journal-title":"EMBO Mol Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.it.2008.10.002","article-title":"Naturally occurring auto-antibodies in homeostasis and disease","volume":"30","author":"Lutz","year":"2009","journal-title":"Trends Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3389\/fimmu.2018.01320","article-title":"Natural autoantibodies: an undersung hero of the immune system and autoimmune disorders\u2014a point of view","volume":"9","author":"Avrameas","year":"2018","journal-title":"Front Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.it.2017.03.008","article-title":"Brain autoimmunity and intestinal microbiota: 100 trillion game changers","volume":"38","author":"Wekerle","year":"2017","journal-title":"Trends Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0092-8674(93)90074-Z","article-title":"Transgenic mice express a myelin basic protein- specific T cell receptor develop spontaneous autoimmunity","volume":"72","author":"Goverman","year":"1993","journal-title":"Cell."},{"key":"B38","doi-asserted-by":"publisher","first-page":"10719","DOI":"10.1073\/pnas.1711233114","article-title":"Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice","volume":"114","author":"Berer","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"eaat4301","DOI":"10.1126\/scitranslmed.aat4301","article-title":"GDP-L-fucose synthetase is a CD4+T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis","volume":"10","author":"Planas","year":"2018","journal-title":"Sci Transl Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"eaau8826","DOI":"10.1126\/scitranslmed.aau8826","article-title":"T cells take aim at a ubiquitous autoantigen in multiple sclerosis","volume":"10","author":"Sabatino","year":"2018","journal-title":"Sci Transl Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.immuni.2015.07.014","article-title":"Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site","volume":"43","author":"Horai","year":"2015","journal-title":"Immunity."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7864","DOI":"10.1073\/pnas.1522730113","article-title":"Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins","volume":"113","author":"Brandle","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B44","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"New Eng J Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nrn.2015.27","article-title":"Autoimmune synaptopathies","volume":"17","author":"Crisp","year":"2016","journal-title":"Nat Rev Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune disease of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00401-011-0876-1","article-title":"Paraneoplastic encephalomyelopathies: pathology and mechanisms","volume":"122","author":"Mckeon","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/B978-0-444-63432-0.00007-4","article-title":"Neuropathology of autoimmune encephalitides","volume":"133","author":"Bauer","year":"2016","journal-title":"Handbook Clin Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3389\/fneur.2019.01394","article-title":"In vivo mechanisms of antibody mediated neurological disorders; animal models and potential implications","volume":"10","author":"Giannoccaro","year":"2020","journal-title":"Front Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ncl.2018.04.015","article-title":"Paraneoplastic neurologic syndrome","volume":"36","author":"Rosenfeld","year":"2018","journal-title":"Neurol Clin."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/jamaneurol.2020.2231","article-title":"Expanded clinical phenotype, oncological associations and immunopathologic insights of paraneoplastic Kelch-like protein-11","volume":"77","author":"Dubey","year":"2020","journal-title":"JAMA Neurol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ana.25173","article-title":"N-Methyl-D-Aspartate receptor antibody production from germinal center reactions: Therapeutic implications","volume":"83","author":"Makuch","year":"2018","journal-title":"Ann Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat Rev Clin Oncol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00401-017-1802-y","article-title":"Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration","volume":"135","author":"Small","year":"2018","journal-title":"Acta Neuropathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3389\/fimmu.2020.00781","article-title":"A brief review of the effects of Vitamin D on multiple sclerosis","volume":"11","author":"Miclea","year":"2020","journal-title":"Front Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/nu12030789","article-title":"Pathophysiological role and therapeutic implications of Vitamin D in autoimmunity: Focus on chronic autoimmune diseases","volume":"12","author":"Bellan","year":"2020","journal-title":"Nutrients."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1177\/1352458517733551","article-title":"Genetic risk factors for pediatric-onset multiple sclerosis","volume":"14","author":"Gianfrancesco","year":"2018","journal-title":"Mult Scler."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1590\/0004-282x20160173","article-title":"No correlation was observed between Vitamin D levels and disability of patients with multiplw sclerosis between latitudes of 18 and 30 South","volume":"75","author":"Fragoso","year":"2017","journal-title":"Arq Neuropsiquiatr."},{"key":"B61","doi-asserted-by":"publisher","first-page":"CD008422","DOI":"10.1002\/14651858.CD008422.pub3","article-title":"Vitamin D for the management of multiple sclerosis","volume":"9","author":"Jagannath","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-0964-2","article-title":"\u03b2synuclein-reactive T cells induce autoimmune CNS greay matter degeneration","volume":"566","author":"Lodygin","year":"2019","journal-title":"Nature."},{"key":"B63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","article-title":"T cells in patients with narcolepsy target self-antigens of hypocretin neurons","volume":"562","author":"Latorre","year":"2018","journal-title":"Nature."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","article-title":"International multicenter examination of MOG antibody assays","volume":"7","author":"Reindl","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B65","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1212\/CON.0000000000000742","article-title":"Neuromyelitis optica spectrum disorder and other non-multiple sclerosis central nervous system inflammatory diseases","volume":"25","author":"Flanagan","year":"2019","journal-title":"Continuum."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain."},{"key":"B67","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/sleep\/33.7.857","article-title":"The trouble with Tribbles: do antibodies against TRIB2 cause narcolepsy","volume":"33","author":"Andrews","year":"2010","journal-title":"Sleep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O'Callaghan","year":"2018","journal-title":"Lancet Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.mayocp.2016.12.025","article-title":"Diagnosis and management of immune-mediated myopathies","volume":"92","author":"Milone","year":"2017","journal-title":"Mayo Clin Proc."},{"key":"B71","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat Rev Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jnnp-2020-325275.","article-title":"Clinical spectrum of high-titre GAD antibodies","author":"Budharan","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B74","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/mdc3.12884","article-title":"Faciobrachial dystonic seizures: the borderland between epilepsy and movement disorders","volume":"7","author":"Morano","year":"2020","journal-title":"Movem Disord Clin Practice."},{"key":"B75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected origin","volume":"7","author":"Pollack","year":"2020","journal-title":"Lancet Psychiatry."},{"key":"B76","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.tins.2016.02.006","article-title":"NMDA receptor internalization by autoantibodies: A reversible mechanism underlying psychosis?","volume":"39","author":"Masdeu","year":"2016","journal-title":"Trends Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel NREM and REM parasomnia with sleep breathing disorder associated with antibodies against IGLON5: a case series, characterization of the antigen and post- mortem studies","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: asyndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1093\/brain\/awz297","article-title":"Glycine receptor autoantibodies disrupt inhibitory neurotransmission","volume":"142","author":"Crisp","year":"2019","journal-title":"Brain."},{"key":"B80","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/WCO.0000000000000450","article-title":"Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors","volume":"30","author":"Crisp","year":"2017","journal-title":"Curr Opin Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/jamaneurol.2016.0133","article-title":"Clinical and immunologic investigations in patients with stiff-person spectrum disorder","volume":"73","author":"Martinez-Hernandez","year":"2016","journal-title":"JAMA Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.survophthal.2019.08.001","article-title":"Optic neuritis in the era of biomarkers","volume":"65","author":"Chen","year":"2020","journal-title":"Survey Opthalmol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed criterion for MOG-IgG-associated disorders","volume":"75","author":"Lopez-Chiriboga","year":"2018","journal-title":"JAMA Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiographic and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e663","DOI":"10.1212\/NXI.0000000000000663","article-title":"Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient","volume":"7","author":"Cellucci","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendation on diagnosis and testing","volume":"89","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation."},{"key":"B88","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanism and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3389\/fimmu.2017.00336","article-title":"Adaptive immunity is the key to the understanding of autoimmune and paraneoplastic inflammatory central nervous system disorders","volume":"8","author":"Weissert","year":"2017","journal-title":"Front Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"R Sabatino","year":"2019","journal-title":"Nat Rev Neuroscience."},{"key":"B92","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nri.2017.24","article-title":"Altered B cell signaling in autoimmunity","volume":"17","author":"Rawlings","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00415-016-8360-4","article-title":"The MRZ reaction as a highly specific marker of multiple sclerosis; re-evaluation and structured review of the literature","volume":"264","author":"Jarius","year":"2017","journal-title":"J Neurol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/brain\/awz106","article-title":"Early B cell tolerance defects in neuromyelitis optica favor anti-AQP4 autoantibody production","volume":"142","author":"Cotzomi","year":"2019","journal-title":"Brain."},{"key":"B95","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1023\/A:1011031014433","article-title":"Immune responses against the myelin\/oligodendrocyte glycoprotein in experimental autoimmune demyelination","volume":"21","author":"von","year":"2001","journal-title":"J Clin Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/archneur.56.3.311","article-title":"Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis","volume":"56","author":"Karni","year":"1999","journal-title":"Arch Neurol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jnnp-2020-325121.","article-title":"Brainstem and cerebellar involvement in MOG0IgG-associated disorder versus aquaporin-4-IgG and MS","author":"Banks","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e924","DOI":"10.1212\/NXI.0000000000000924","article-title":"Overlapping central and peripheral nervous system syndromes in MOG-antibody associated disorders","volume":"8","author":"Rinaldi","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1093\/brain\/aww208","article-title":"Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain."},{"key":"B100","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"28","author":"Hughes","year":"2010","journal-title":"J Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behavior in mice","volume":"138","author":"Planaguma","year":"2015","journal-title":"Brain."},{"key":"B102","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/epi.14662","article-title":"A mouse model of seizures in anti-N-methyl-D-aspartate receptor encephalitis","volume":"60","author":"Taraschenko","year":"2019","journal-title":"Epilepsia."},{"key":"B103","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1093\/brain\/awv257","article-title":"Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model","volume":"138","author":"Wright","year":"2015","journal-title":"Brain."},{"key":"B104","doi-asserted-by":"publisher","first-page":"eeaaw0044","DOI":"10.1126\/scitranslmed.aaw0044","article-title":"Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors","volume":"11","author":"Jones","year":"2019","journal-title":"Sci Transl Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.tjog.2017.04.009","article-title":"Anti-N-Methyl-D-Aspartate receptor encephalitis during pregnancy: clinical analysis of reported cases","volume":"56","author":"Shi","year":"2017","journal-title":"Taiwan J Obstet Gynaecol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/archneurol.2010.133","article-title":"Anti-N-methyl \u2013D-aspartate receptor encephalitis during pregnancy","volume":"67","author":"Kumar","year":"2010","journal-title":"JAMA Neurol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acn3.547","article-title":"Seronegative antibody-mediated neurology after immune checkpoint inhibitors","volume":"5","author":"Wilson","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"Toyka","year":"1975","journal-title":"Science."},{"key":"B109","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain- Barre syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"New Eng J Med."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325300.","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B112","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.0000000000003536","article-title":"Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis","volume":"88","author":"Scheibe","year":"2017","journal-title":"Neurology."},{"key":"B114","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain."},{"key":"B115","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain."},{"key":"B116","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"New Eng J Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ana.26049.","article-title":"Long-term safety and efficacy of eculizumab in aquaporin-4 IgG-positive NMOSD","author":"Wingerchuk","year":"2021","journal-title":"Ann Neurol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25119","article-title":"B cell therapy for Multiple sclerosis; entering an era","volume":"83","author":"Greenfield","year":"2018","journal-title":"Ann Neurol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"25800","DOI":"10.1073\/pnas.1915309116","article-title":"Anti CD20 therapy depletes activated myelin specific CD8+ T cells in multiple sclerosis","volume":"116","author":"Sabatino","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B120","article-title":"Persistent B lymphocytes in multiple sclerosis plaques after Rituximab treatment (P5.341)","volume":"88","author":"Esfandi","year":"2019","journal-title":"Neurology."},{"key":"B121","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg based cell therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Ominguez-Villar","year":"2018","journal-title":"Nat Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.05.003","article-title":"Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2 triggered inhibition of effector T cells","volume":"92","author":"Kim","year":"2018","journal-title":"J Autoimmunity."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1182\/blood-2004-09-3579","article-title":"Immunotherapy of autoimmune encephalomyelitis with redirected CD4+ CD25+ T lymphocytes","volume":"105","author":"Mekala","year":"2005","journal-title":"Blood."},{"key":"B126","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science."},{"key":"B128","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1093\/brain\/awaa195","article-title":"Allosteric modulation of NMDA receptors prevent the antibody effects of patients with anti-NMDAR encephalitis","volume":"143","author":"Mannara","year":"2020","journal-title":"Brain."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.664664\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T06:25:51Z","timestamp":1618381551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.664664\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":129,"alternative-id":["10.3389\/fneur.2021.664664"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.664664","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"article-number":"664664"}}